These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12198876)

  • 1. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
    Theisen J; Siewert JR
    MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
    Hölscher AH; Metzger R; Schneider PM
    Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has combined modality therapy improved the outlook in carcinoma of the esophagus?
    Philip PA; Ajani JA
    Oncology (Williston Park); 1994 Sep; 8(9):37-42; discussion 44-5, 50-2, 61. PubMed ID: 7527642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
    Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interdisciplinary multi-modality therapy of advanced hypopharyngeal and proximal esophageal carcinomas].
    Fass J; Dreuw B; Korves B; von Saldern S; Andreopoulos B; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1502-4. PubMed ID: 9931925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current diagnosis and therapy of esophageal carcinoma].
    Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
    Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal carcinoma: impact of staging on treatment.
    Siewert JR; Dittler HJ
    Endoscopy; 1993 Jan; 25(1):28-32. PubMed ID: 8453923
    [No Abstract]   [Full Text] [Related]  

  • 8. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 9. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
    Incarbone R; Bonavina L
    Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
    [No Abstract]   [Full Text] [Related]  

  • 10. Section II: pathology and pathologic staging of esophageal cancer.
    Glickman JN
    Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):167-79. PubMed ID: 12838487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.
    Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M
    Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the medical management of advanced gastrointestinal cancers.
    Tempero MA
    Curr Opin Oncol; 1990 Aug; 2(4):747-53. PubMed ID: 2095882
    [No Abstract]   [Full Text] [Related]  

  • 14. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
    Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esophageal carcinoma -- current status in diagnosis and therapy].
    Baumhoer D; Ramadori G
    Z Gastroenterol; 2005 Apr; 43(4):399-409. PubMed ID: 15830307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological profile of carcinoma of oesophagus at Aligarh.
    Ansari MM; Beg MH; Haleem S
    J Indian Med Assoc; 1991 Aug; 89(8):217-9. PubMed ID: 1721079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliation of carcinoma of the esophagus: is there a hope for cure?
    Lambert R
    Am J Gastroenterol; 1994 Aug; 89(8 Suppl):S27-40. PubMed ID: 7519392
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
    Fuchs HF; Hölscher AH
    Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of early esophageal cancer: differences between squamous cell carcinoma and adenocarcinoma.
    Bollschweiler E; Hölscher AH
    Ann Surg; 2007 Feb; 245(2):334. PubMed ID: 17245190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.